VACUMED® (IVT) & Cerebral & Cognitive Function

What It Does for the Brain (In a Nutshell) [3,11]

• Endothelial shear → Nitric oxide (NO): IVT’s rhythmic dilation/compression raises endothelial shear and NO; the material explicitly notes NO dilates arterial vessels “also cerebral.” This mechanistically supports cerebral perfusion and vitality. [1–4,7–8]
• Systemic flow + CNS co-stimulation: By alternating lower-body negative and positive pressure, IVT increases arterial inflow, venous/lymphatic return and also stimulates the central nervous system (CNS). [7,9–10]
• Neuro-rehab use cases already listed: Stroke, MS, polyneuropathy, fibromyalgia are named neurological indications across the rehab papers. [3,11]

Evidence & Clinical Signals (Selected) [1–5]

• Stroke rehab (Phase C): Framed as vascular training that promotes mobilization and integrates into MTT without straining patient capacity. [3,11]
• Multiple Sclerosis: Maintains/increases capillarization, promotes mobility, may delay progression, pain relief via flow promotion.
• Polyneuropathy: Endothelial stimulation → NO release, more sensors/capillarization; mobility & stability benefits. [1–4,7–8]
• Fibromyalgia: Systemic pain therapy, no strain on personal capacity. [1–4,7–8]
• Physiology & parameterization (peer/clinic reports): Typical negative pressure −20 to −70 mbar, with 5–21 s negative and 5–10 s pressure/pause phases; starting low (≈−25 mbar) for first treatment is advised. [1–4,7–8]

Takeaway for neurologists: IVT provides a hemodynamic training stimulus that plausibly augments cerebral perfusion via NO-mediated vasodilation, while delivering low-effort vascular conditioning valuable in stroke, MS, neuropathy, and centralized pain populations. [1–4,7–8]

Practical IVT Protocols (Neurology-Focused)

General Parameters (VACUMED® LBNPD)

• Start ~−25 mbar, titrate by tolerance.
• Negative phase 5–21 s, pressure/pause 5–10 s.
• Session duration 25–30 minutes.

Note: Conservative escalation; neurologic patients often prefer symmetric intervals. [7,9–10]

1) Post-Stroke (Phase C Rehab) [3,11]

• Goal: Cerebral perfusion support + early mobilization adjunct without effort. [1–4,7–8]
• Session: 25–30 min. Start −25 to −35 mbar, 7–10 s neg / 7–10 s pause; progress over sessions toward −40 to −50 mbar keeping symmetry of intervals. [7,9–10]
• Frequency: 3–5×/week during inpatient rehab, then 2–3×/week outpatient.
• Notes: Integrate near gait/MTT blocks to leverage carry-over on endurance.

2) Multiple Sclerosis (Fatigue, Mobility)

• Goal: Microvascular support (capillarization), flow-mediated symptom relief.
• Session: 25–30 min. −25 to −45 mbar, 8–12 s neg / 8–10 s pause. [7,9–10]
• Frequency: 2–3×/week ongoing block cycles (6–12 weeks), then weekly maintenance.

3) Polyneuropathy (Sensory, Stability) [3,11]

• Goal: Endothelial stim + NO release; improve sensorimotor stability. [1–4,7–8]
• Session: 25–30 min. −25 → −50 mbar as tolerated, 10–15 s neg / 8–10 s pause. [7,9–10]
• Frequency: 2–3×/week for 6–8 weeks, reassess.

4) Fibromyalgia (Centralized Pain)

• Goal: Systemic flow for pain modulation with zero exertional load.
• Session: 25–30 min. Low-to-moderate: −20 to −40 mbar, 7–12 s neg / 7–10 s pause. [7,9–10]
• Frequency: 2–3×/week initially; taper to weekly if stable.

For complex vascular comorbidity, clinics have used staged step-up blocks within a 30-min session (e.g., 6-min tiers at 35→60 mbar with 8–10 s intervals) to drive microperfusion without intolerance. Adjust conservatively in neurologic patients. [1–4,7–8]

Outcome Measures to Track (Neuro + Hemo)

• Cognition: MoCA, Trail Making Test A/B.
• Function: 6MWT, 10MWT, BBS, FAC/FIM.
• Symptoms: Fatigue Severity Scale (MS), VAS pain, DN4 (neuropathic pain). [3,11]
• Hemodynamics: Rest/orthostatic BP/HR; ABI, TcPO₂ at feet as a systemic perfusion proxy; some centers observed meaningful TcPO₂ rises after IVT blocks. [1–4,7–8]
• Safety: Rate perceived exertion (should remain low), dizziness, headache. [6,9–10]

Safety & Contraindications (Screening) [6,9–10]

• Do not treat: Acute thrombosis/thrombophlebitis (<8 weeks), unstable angina, inguinal/abdominal wall hernia, pregnancy. Use caution in severe hypertension; treat under trained supervision.
• Device/setting: Medical-grade device, trained operators; IVT is passive and generally well tolerated; CNS stimulation is noted but without compression.

Language to Use with Neurologists

“Passive vascular conditioning that increases endothelial shear and NO; evidence of improved peripheral perfusion and CNS co-stimulation; used as an adjunct to conventional neuro-rehab to support mobilization and endurance with minimal patient effort.” [1–4,7–8]